Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings

By sjmartinez • June 3, 2024

LoVecchio F, McCarthy MW, Ye X, Henry AD, Doan QV, Lock JL, Riccobene T, Lyles RD, Talan DA. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings. J Emerg Med. 2024 Mar 12:S0736-4679(24)00071-4. doi: 10.1016/j.jemermed.2024.03.003. Epub ahead of print. PMID: 38825531.

Tags: ABSSSI, Cost, Dalbavancin, Emergency Medicine, Long-acting antibiotic, Olive View DoM, Publications, Single-dose regimen

eConsult-Integrated Care to Improve Specialty Access

Bergman J, Giboney P, Waterman B, Yee H. eConsult-Integrated Care to Improve Specialty Access. JAMA Intern Med. 2026 Mar 16. doi: 10.1001/jamainternmed.2025.8352. Epub ahead of[...]

Pilot demonstration for physician compensation incentives to improve diagnostic specificity in clinical documentation

Burstein DS, Schwartz N, Ganguly A, Hanak MA, Zimmermann LJ, Keshavarzian A. Pilot demonstration for physician compensation incentives to improve diagnostic specificity in clinical documentation.[...]

Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic Sclerosis

Delgadillo R, Roufeh E, Lavelle B, Nguyen K, de la Rosa A. Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic[...]